Notice of Compliance Information
From Health Canada
- Notice of Compliance date :
- 2021-01-18
- Manufacturer :
- ASTRAZENECA CANADA INC
- Product type:
- Prescription Pharmaceutical
- NOC with conditions:
- No
- Submission type:
- Supplement to a New Drug Submission (SNDS)
- Reason for supplement:
- NEW INDICATION
- Submission class:
- Priority
Brand 1 of 1 :
TAGRISSO
Product 1 of 2 :
Drug identification number:
00000N/A
Dosage form(s):
Tablet
Route(s) of administration:
Oral
| Ingredient | Strength |
|---|---|
| OSIMERTINIB MESYLATE | 40 MG/TAB |
Product 2 of 2 :
Drug identification number:
00000N/A
Dosage form(s):
Tablet
Route(s) of administration:
Oral
| Ingredient | Strength |
|---|---|
| OSIMERTINIB MESYLATE | 80 MG/TAB |